We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Abcam Plc | LSE:ABC | London | Ordinary Share | GB00B6774699 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1,226.00 | 1,240.00 | 1,246.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMABC
RNS Number : 1775J
ABCAM Plc
01 April 2015
For immediate release 1 April 2015
ABCAM PLC
("Abcam" or "the Company")
Total Voting Rights - Voting Rights and Capital
In conformity with 5.6.1 of the Disclosure and Transparency Rules, the Company notifies the market of the following:
The Company's issued share capital consists of 200,945,299 Ordinary Shares of 0.2p each with voting rights. The Company does not hold any shares in Treasury.
The above figure of 200,945,299 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules.
Date of Notification: 1 April 2015
For further information please contact:
+ 44 (0) 1223 Abcam 696 000 Jeff Iliffe, Chief Financial Officer Laura Taylor, Investor Relations Manager J.P.Morgan Cazenove - Nominated Adviser & Joint + 44 (0) 20 7742 Corporate Broker 4000 James Mitford / Alex Bruce - Nominated Adviser + 44 (0) 20 7418 Peel Hunt LLP - Joint Corporate Broker 8900 Clare Terlouw / Jock Maxwell MacDonald - Corporate Broking +44 (0) 20 7404 Brunswick 5959 Sarah West / Will Medvei / Katarina Sallerfors
Notes to Editors
About Abcam
Abcam plc is a global leader in the supply of life science research tools, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level and improving the understanding of health and disease.
Abcam is committed to providing scientists with an extensive choice of reagents and tools, with the most comprehensive, honest and up-to-date datasheets and customer reviews, fast delivery and helpful customer service & technical support. The Company's catalogue evolves with scientific research trends and is growing each year to provide customers with products to meet their research needs. The range now includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam also supports its customers by hosting a range of global scientific events, forums and webinars, providing opportunities for scientists to get together and present their work.
Headquartered in Cambridge, UK, Abcam has nine global subsidiary offices enabling local services and multi-language support and sells to over 100 countries. The Company was founded in 1998, and now employs over 800 people. Abcam was admitted to AIM in 2005 (AIM: ABC).
To find out more, please visit www.abcam.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVRUGURCCUPAGUG
1 Year Abcam Chart |
1 Month Abcam Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions